(Q33350227)

26 July 2017

1 reference

title

A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor (English)

1 reference

antiphospholipid syndrome

26 July 2017

main subject

1 reference

2

Shoenfeld Y

1 reference

26 July 2017

1

Valesini G

1 reference

26 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1303677

11 September 2022

publication date

1 January 1992

1 reference

26 July 2017

1 reference

26 July 2017

volume

14

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

105-110

1 reference

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Antiphospholipid antibody syndrome: immunologic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Antiphospholipid syndrome: linking many specialties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

The relation of sex, smoking status, birth rank, and parental age to beta2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Characterization of plasma lipids and lipoproteins in patients with beta 2-glycoprotein I (apolipoprotein H) deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

Complete amino acid sequence of human plasma beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939209083128

10.3109/08916939209083128

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference